February 14th, 2012

Complete Genomics To Provide Services To Mayo Clinic; Shares Up

By

Complete Genomics Inc. (GNOM) was chosen by Mayo Clinic's Center for Individualized Medicine to provide whole human genome sequencing outsourcing services, to supplement the nonprofit research hospital's in-house gene-sequencing laboratory. Complete Genomics shares rose nearly 24% to $4.07 in recent premarket trading. Through Friday's close, the stock is up nearly 49% from its all-time low in January, as the sector received a big lift from Swiss drug giant Roche Holding Ltd.'s (ROG.VX) hostile offer for Illumina Inc. (ILMN), which makes tools for DNA sequencing.

Wall Street Journal, 02/13/2012

Additional coverage: Wall St. Cheat Sheet, CBS News, Reuters, GenomeWeb

Tags: Complete Genomics Inc., Finanical, Genomics, GNOM, human genome sequencing outsourcing services, Illumina Inc., ILMN, Mayo Clinc's Center for Individualized Medicine, Roche Holding Ltd., ROG.VX

Contact Us · Privacy Policy